Pioglitazone reduces cardiovascular disease risk in SLE patients: Study - Medical Dialogues
8/5/2022 12:00:00 AM2 years 8 months ago
by Medha Baranwal
by Medha Baranwal
USA: Pioglitazone (Actos) treatment could reduce the risk of cardiovascular disease (CVD) in...
USA: Pioglitazone (Actos) treatment could reduce the risk of cardiovascular disease (CVD) in patients with systemic lupus erythematosus (SLE) without hampering the immune mechanisms, according to res… [+2737 chars]
full article...